Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies.

Cortelli P, Allais G, Tullo V, Benedetto C, Zava D, Omboni S, Bussone G.

Neurol Sci. 2011 May;32 Suppl 1:S95-8. doi: 10.1007/s10072-011-0551-2.

PMID:
21533722
2.

Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study.

Tullo V, Allais G, Ferrari MD, Curone M, Mea E, Omboni S, Benedetto C, Zava D, Bussone G.

Neurol Sci. 2010 Jun;31 Suppl 1:S51-4. doi: 10.1007/s10072-010-0273-x.

3.

Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.

Allais G, Tullo V, Omboni S, Benedetto C, Sances G, Zava D, Ferrari MD, Bussone G.

Neurol Sci. 2012 May;33 Suppl 1:S65-9. doi: 10.1007/s10072-012-1044-7.

4.

Frovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.

Allais G, Tullo V, Omboni S, Pezzola D, Zava D, Benedetto C, Bussone G.

Neurol Sci. 2013 May;34 Suppl 1:S83-6. doi: 10.1007/s10072-013-1393-x.

5.

A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.

Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L.

J Headache Pain. 2011 Apr;12(2):219-26. doi: 10.1007/s10194-010-0243-y.

6.

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan.

Allais G, Tullo V, Benedetto C, Zava D, Omboni S, Bussone G.

Neurol Sci. 2011 May;32 Suppl 1:S99-104. doi: 10.1007/s10072-011-0547-y.

7.

Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study.

Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Fierro B, Brighina F.

J Headache Pain. 2012 Jul;13(5):401-6. doi: 10.1007/s10194-012-0455-4.

8.

Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans.

Franconi F, Finocchi C, Allais G, Omboni S, Tullo V, Campesi I, Reggiardo G, Benedetto C, Bussone G.

Neurol Sci. 2014 May;35 Suppl 1:99-105. doi: 10.1007/s10072-014-1750-4. Review.

9.

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.

Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L.

J Headache Pain. 2011 Dec;12(6):609-15. doi: 10.1007/s10194-011-0366-9.

10.

Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies.

Tullo V, Bussone G, Omboni S, Barbanti P, Cortelli P, Curone M, Peccarisi C, Benedetto C, Pezzola D, Zava D, Allais G.

Neurol Sci. 2013 May;34 Suppl 1:S87-91. doi: 10.1007/s10072-013-1367-z. Review.

PMID:
23695053
11.

A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine.

Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Brighina F, Fierro B.

J Headache Pain. 2011 Jun;12(3):361-8. doi: 10.1007/s10194-011-0325-5.

12.

Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian study.

Tullo V, Allais G, Curone M, Ferrari MD, Omboni S, Benedetto C, Colombo B, Zava D, Bussone G.

Neurol Sci. 2012 May;33 Suppl 1:S61-4. doi: 10.1007/s10072-012-1043-8.

13.

Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials.

Poolsup N, Leelasangaluk V, Jittangtrong J, Rithlamlert C, Ratanapantamanee N, Khanthong M.

J Clin Pharm Ther. 2005 Dec;30(6):521-32. Review.

PMID:
16336284
14.

Safety and tolerability of short-term preventive frovatriptan: a combined analysis.

MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.

Headache. 2009 Oct;49(9):1298-314. doi: 10.1111/j.1526-4610.2009.01513.x.

PMID:
19788471
15.

Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies.

Saracco MG, Allais G, Tullo V, Zava D, Pezzola D, Reggiardo G, Omboni S, Benedetto C, Bussone G, Aguggia M.

Neurol Sci. 2014 May;35 Suppl 1:115-9. doi: 10.1007/s10072-014-1752-2. Review.

PMID:
24867847
16.

Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.

Guidotti M, Ravasio R.

Clin Drug Investig. 2009;29(11):693-702. doi: 10.2165/11315330-000000000-00000. Review.

PMID:
19813772
17.

Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.

Savi L, Mogavero S, Egan CG.

Drug Des Devel Ther. 2014 Jul 21;8:983-92. doi: 10.2147/DDDT.S61295.

18.

Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).

Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ; AEGIS Investigator Study Group..

Headache. 2007 Feb;47(2):189-98.

PMID:
17300358
20.

Frovatriptan and rizatriptan economic EVAluation: the FREEVA study.

Lisotto C, Guidotti M, Zava D, Savi L.

J Headache Pain. 2013 Dec 11;14:96. doi: 10.1186/1129-2377-14-96.

Items per page

Supplemental Content

Support Center